Genelux (GNLX) Enterprise Value (2022 - 2026)
Genelux's (GNLX) quarterly Enterprise Value came in at -$9.3 million in Q1 2026, up 32.8% year-on-year from -$7.0 million in Q1 2025, and up 24.09% quarter-over-quarter from -$12.2 million in Q4 2025.
Genelux (GNLX) Enterprise Value (2022 - 2026) Analysis & Trends
Genelux's Enterprise Value history runs 5 years deep, the most recent figure standing at -$9.3 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 32.8% year-over-year to -$9.3 million in Q1 2026; TTM through Mar 2026 was -$9.3 million, a 32.8% increase from a year earlier, with the FY2025 full-year figure at -$12.2 million, up 60.46% from the prior year.
- Enterprise Value advanced to -$9.3 million in Q1 2026 per GNLX's latest filing, from -$12.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$397000.0 in Q4 2022 and bottomed at -$66.2 million in Q2 2024.
- The 5-year median for Enterprise Value is -$25.8 million (2023), against an average of -$29.2 million.
- Across the five-year window, Enterprise Value slumped 5365.24% in 2023 and surged 66.52% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$397000.0 in 2022, then slumped by 5365.24% to -$21.7 million in 2023, then tumbled by 42.39% to -$30.9 million in 2024, then jumped by 60.46% to -$12.2 million in 2025, then climbed by 24.09% to -$9.3 million in 2026.
- Per Business Quant, the three latest GNLX Enterprise Value figures stand at -$9.3 million (Q1 2026), -$12.2 million (Q4 2025), and -$20.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -9.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.27 Mn |
| Dec 31, 2025 | -12.22 Mn |
| Sep 30, 2025 | -20.90 Mn |
| Jun 30, 2025 | -47.65 Mn |
| Mar 31, 2025 | -13.80 Mn |
| Dec 31, 2024 | -30.90 Mn |
| Sep 30, 2024 | -62.42 Mn |
| Jun 30, 2024 | -66.23 Mn |
| Mar 31, 2024 | -35.19 Mn |
| Dec 31, 2023 | -21.70 Mn |
| Sep 30, 2023 | -29.87 Mn |
| Dec 31, 2022 | -397,000.00 |